Zeltiq Aesthetics Inc (ZLTQ) : Drill Craig A reduced its stake in Zeltiq Aesthetics Inc by 30.27% during the most recent quarter end. The investment management company now holds a total of 285,800 shares of Zeltiq Aesthetics Inc which is valued at $7 Million after selling 124,044 shares in Zeltiq Aesthetics Inc , the firm said in a disclosure report filed with the SEC on May 11, 2016.Zeltiq Aesthetics Inc makes up approximately 17.35% of Drill Craig A’s portfolio.
Other Hedge Funds, Including , Teacher Retirement System Of Texas boosted its stake in ZLTQ in the latest quarter, The investment management firm added 961 additional shares and now holds a total of 3,848 shares of Zeltiq Aesthetics Inc which is valued at $93,699.Provident Investment Management boosted its stake in ZLTQ in the latest quarter, The investment management firm added 118,381 additional shares and now holds a total of 454,031 shares of Zeltiq Aesthetics Inc which is valued at $11.1 Million. Zeltiq Aesthetics Inc makes up approx 2.30% of Provident Investment Management’s portfolio.Manufacturers Life Insurance Company The boosted its stake in ZLTQ in the latest quarter, The investment management firm added 289 additional shares and now holds a total of 21,541 shares of Zeltiq Aesthetics Inc which is valued at $524,523.New York State Common Retirement Fund boosted its stake in ZLTQ in the latest quarter, The investment management firm added 5,337 additional shares and now holds a total of 46,869 shares of Zeltiq Aesthetics Inc which is valued at $1.4 Million.
Zeltiq Aesthetics Inc closed down -0.07 points or -0.29% at $24.28 with 9,72,300 shares getting traded on Monday. Post opening the session at $24.58, the shares hit an intraday low of $23.76 and an intraday high of $24.71 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Zeltiq Aesthetics Inc reported $-0.25 EPS for the quarter, missing the analyst consensus estimate by $ -0.01 based on the information available during the earnings call on May 10, 2016. Analyst had a consensus of $-0.24. The company had revenue of $64.50 million for the quarter, compared to analysts expectations of $61.87 million. The company’s revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.06 EPS.
Many Wall Street Analysts have commented on Zeltiq Aesthetics Inc. Zeltiq Aesthetics Inc was Initiated by Brean Capital to “Buy” on Apr 13, 2016. Shares were Reiterated by Maxim Group on Mar 1, 2016 to “Buy” and Lowered the Price Target to $ 40 from a previous price target of $50 .
ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.